These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Molecular basis for the glycosphingolipid-binding specificity of α-synuclein: key role of tyrosine 39 in membrane insertion. Fantini J; Yahi N J Mol Biol; 2011 May; 408(4):654-69. PubMed ID: 21396938 [TBL] [Abstract][Full Text] [Related]
4. Interactions of amyloid beta-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid. Kakio A; Nishimoto S; Yanagisawa K; Kozutsumi Y; Matsuzaki K Biochemistry; 2002 Jun; 41(23):7385-90. PubMed ID: 12044171 [TBL] [Abstract][Full Text] [Related]
6. Gene Therapy Strategy for Alzheimer's and Parkinson's Diseases Aimed at Preventing the Formation of Neurotoxic Oligomers in SH-SY5Y Cells. El-Battari A; Rodriguez L; Chahinian H; Delézay O; Fantini J; Yahi N; Di Scala C Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768981 [TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease: NMR studies of asialo (GM1) and trisialo (GT1b) ganglioside interactions with Abeta(1-40) peptide in a membrane mimic environment. Mandal PK; Pettegrew JW Neurochem Res; 2004 Feb; 29(2):447-53. PubMed ID: 15002743 [TBL] [Abstract][Full Text] [Related]
8. Cholesterol accelerates the binding of Alzheimer's β-amyloid peptide to ganglioside GM1 through a universal hydrogen-bond-dependent sterol tuning of glycolipid conformation. Fantini J; Yahi N; Garmy N Front Physiol; 2013; 4():120. PubMed ID: 23772214 [TBL] [Abstract][Full Text] [Related]
9. Characterization of high-affinity binding between gangliosides and amyloid beta-protein. Ariga T; Kobayashi K; Hasegawa A; Kiso M; Ishida H; Miyatake T Arch Biochem Biophys; 2001 Apr; 388(2):225-30. PubMed ID: 11368158 [TBL] [Abstract][Full Text] [Related]
10. Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosides. Di Pasquale E; Fantini J; Chahinian H; Maresca M; Taïeb N; Yahi N J Mol Biol; 2010 Mar; 397(1):202-18. PubMed ID: 20114052 [TBL] [Abstract][Full Text] [Related]
11. AmyP53 Prevents the Formation of Neurotoxic β-Amyloid Oligomers through an Unprecedent Mechanism of Interaction with Gangliosides: Insights for Alzheimer's Disease Therapy. Azzaz F; Chahinian H; Yahi N; Fantini J; Di Scala C Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675271 [TBL] [Abstract][Full Text] [Related]
12. Ganglioside binding domains in proteins: Physiological and pathological mechanisms. Azzaz F; Yahi N; Di Scala C; Chahinian H; Fantini J Adv Protein Chem Struct Biol; 2022; 128():289-324. PubMed ID: 35034721 [TBL] [Abstract][Full Text] [Related]
13. Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. Rusnati M; Tanghetti E; Urbinati C; Tulipano G; Marchesini S; Ziche M; Presta M Mol Biol Cell; 1999 Feb; 10(2):313-27. PubMed ID: 9950679 [TBL] [Abstract][Full Text] [Related]
14. AmyP53, a Therapeutic Peptide Candidate for the Treatment of Alzheimer's and Parkinson's Disease: Safety, Stability, Pharmacokinetics Parameters and Nose-to Brain Delivery. Di Scala C; Armstrong N; Chahinian H; Chabrière E; Fantini J; Yahi N Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362170 [TBL] [Abstract][Full Text] [Related]
15. Common molecular mechanism of amyloid pore formation by Alzheimer's β-amyloid peptide and α-synuclein. Di Scala C; Yahi N; Boutemeur S; Flores A; Rodriguez L; Chahinian H; Fantini J Sci Rep; 2016 Jun; 6():28781. PubMed ID: 27352802 [TBL] [Abstract][Full Text] [Related]
16. Cyclization of Peptides Enhances the Inhibitory Activity against Ganglioside-Induced Aβ Fibril Formation. Miyamoto E; Sato T; Matsubara T ACS Chem Neurosci; 2023 Dec; 14(23):4199-4207. PubMed ID: 37971427 [TBL] [Abstract][Full Text] [Related]
17. Gangliosides in nervous system development, regeneration, and pathologies. Vasques JF; de Jesus Gonçalves RG; da Silva-Junior AJ; Martins RS; Gubert F; Mendez-Otero R Neural Regen Res; 2023 Jan; 18(1):81-86. PubMed ID: 35799513 [TBL] [Abstract][Full Text] [Related]
18. The driving force of alpha-synuclein insertion and amyloid channel formation in the plasma membrane of neural cells: key role of ganglioside- and cholesterol-binding domains. Fantini J; Yahi N Adv Exp Med Biol; 2013; 991():15-26. PubMed ID: 23775688 [TBL] [Abstract][Full Text] [Related]
19. Ganglioside Micelles Affect Amyloid β Aggregation by Coassembly. Hu J; Linse S; Sparr E ACS Chem Neurosci; 2023 Dec; 14(24):4335-4343. PubMed ID: 38050745 [TBL] [Abstract][Full Text] [Related]
20. An 11-mer Amyloid Beta Peptide Fragment Provokes Chemical Mutations and Parkinsonian Biomarker Aggregation in Dopaminergic Cells: A Novel Road Map for "Transfected" Parkinson's. Kabiraj P; Marin JE; Varela-Ramirez A; Narayan M ACS Chem Neurosci; 2016 Nov; 7(11):1519-1530. PubMed ID: 27635664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]